Clinical Trial Update: Study of PI-88 in Patients With Advanced Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for PI-88 in advanced melanoma spanning Phase 1 and Phase 2, status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• PI-88

Snippet

Sponsor: Cellxpert Biotechnology Corp. | Conditions: Melanoma | Phase 1, Phase 2 | Status: COMPLETED